Connect with us

Subscribe

biotech

Scientists target Alzheimer’s disease

(USA)

A breakthrough by scientists at the State University of New Jersey will help make stem cell transplantations more impactful.

The ‘tiny, biodegradable scaffold’ developed by the Rutgers team is designed to effectively transport stem cells and drugs to target Alzheimer’s and Parkinson’s diseases, and other life limiting conditions. This infrastructure moves stem cells to their destination, without them dying off, allowing them to deliver on their potential.

“It’s been a major challenge to develop a reliable therapeutic method for treating central nervous system diseases and injuries,” explained study senior author KiBum Lee, a professor in the Department of Chemistry and Chemical Biology at Rutgers University-New Brunswick. “Our enhanced stem cell transplantation approach is an innovative potential solution.”

The study was published in Nature Communications.

 

Newsletter Signup

Written By

Advertisement

Connect
Newsletter Signup